Brief: Elevation Oncology Reports Second Quarter 2021 Financial Results
12/08/2021 23:07
Aug 12 (Reuters) - Elevation Oncology Inc ELEV.O :
* ELEVATION ONCOLOGY REPORTS SECOND QUARTER 2021 FINANCIAL
RESULTS
* ELEVATION ONCOLOGY INC - AS OF JUNE 30, 2021, COMPANY HAD
CASH
AND CASH EQUIVALENTS TOTALING $158.0 MILLION
* ELEVATION ONCOLOGY INC - QTRLY LOSS PER SHARE $4.84
Source text for Eikon: ID:nPnbcLqp6a
Further company coverage: ELEV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Elevation Oncology
See all newsBrief: Elevation Oncology Terminates License Agreement With CSPC Megalith Biopharmaceutical
U.S. RESEARCH ROUNDUP- Crane, Ryder System, Terex
Brief: Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR
Elevation Oncology Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Elevation Oncology Inc - To Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022 - SEC Filing